Biogen/Sobi's Eloctate meets all endpoints in Kids trial
This article was originally published in Scrip
Executive Summary
Biogen Idec and partner Sobi (Swedish Orphan Biovitrum) have release positive top-line pediatric data for investigational hemophilia drug Eloctate.